Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Date	Time	Source	Headline	Symbol	Company
02/14/2023	5:07PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
02/14/2023	4:37PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
02/09/2023	11:49AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
02/08/2023	1:59PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
02/07/2023	5:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
02/07/2023	5:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
02/07/2023	5:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
02/06/2023	2:54PM	Edgar (US Regulatory)	Schedule 13g (sc 13g/a)	NASDAQ:IMGN	ImmunoGen Inc
02/01/2023	4:30PM	Business Wire	ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences	NASDAQ:IMGN	ImmunoGen Inc
01/04/2023	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
01/04/2023	4:23PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
01/04/2023	4:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
01/04/2023	4:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
01/04/2023	6:39AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
01/04/2023	6:30AM	Business Wire	ImmunoGen Appoints Michael Vasconcelles, MD, as Executive Vice President, Research, Development, and Medical Affairs	NASDAQ:IMGN	ImmunoGen Inc
01/03/2023	5:22PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
01/03/2023	5:16PM	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:IMGN	ImmunoGen Inc
12/28/2022	4:41PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:IMGN	ImmunoGen Inc
12/28/2022	4:30PM	Business Wire	ImmunoGen Announces Susan Altschuller on FMLA Leave; Interim CFO Appointed	NASDAQ:IMGN	ImmunoGen Inc
12/27/2022	5:19PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
12/27/2022	5:17PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
12/27/2022	5:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:IMGN	ImmunoGen Inc
12/27/2022	4:31PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:IMGN	ImmunoGen Inc
12/27/2022	4:30PM	Business Wire	ImmunoGen Announces Webcast of Presentation and Q&A at the 41st Annual J.P. Morgan Healthcare Conference	NASDAQ:IMGN	ImmunoGen Inc
12/10/2022	10:30AM	Business Wire	ImmunoGen Presents Findings from Expansion Cohorts in Phase 1b/2 Study of Pivekimab Sunirine with Vidaza® and Venclexta® in Acute Myeloid Leukemia at ASH	NASDAQ:IMGN	ImmunoGen Inc
12/09/2022	8:56AM	TipRanks	ImmunoGen Joins hands with Gilead on AML Therapy	NASDAQ:IMGN	ImmunoGen Inc
12/09/2022	6:30AM	Business Wire	ImmunoGen Announces Clinical Collaboration with Gilead to Evaluate Pivekimab Sunirine in Combination with Magrolimab in Relapsed/Refractory Acute Myeloid Leukemia	NASDAQ:IMGN	ImmunoGen Inc
12/01/2022	4:30PM	Business Wire	ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMGN	ImmunoGen Inc
11/21/2022	6:30AM	Business Wire	ImmunoGen Appoints Daniel Char as Senior Vice President and Chief Legal Officer	NASDAQ:IMGN	ImmunoGen Inc
11/16/2022	2:56AM	TipRanks	SVB Securities Reaffirms Their Hold Rating on ImmunoGen (IMGN)	NASDAQ:IMGN	ImmunoGen Inc

Showing the most relevant articles for your search:NASDAQ:IMGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>

Ethema Health (PK)

Northwest Biotherapeutics (QB)

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

1812 Brewing (PK)

Faraday Future Intellige...

Digital Brand Media and ... (PK)

Fannie Mae (QB)

SMC Entertainment (PK)

Anavex Life Sciences

Emergent Health (PK)

Bioelectronics (PK)

Branded Legacy (PK)

Delayed Upgrade Clock